{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:43:22Z","timestamp":1789645402390,"version":"4.0.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL051636"],"award-info":[{"award-number":["HL051636"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI080313"],"award-info":[{"award-number":["AI080313"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI087511"],"award-info":[{"award-number":["AI087511"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI-70022"],"award-info":[{"award-number":["AI-70022"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI-036219"],"award-info":[{"award-number":["P30 AI-036219"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00705-015-2640-7","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T07:45:59Z","timestamp":1445586359000},"page":"181-187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Productive HIV-1 infection is enriched in CD4-CD8- double negative (DN) T cells at pleural sites of dual infection with HIV and Mycobacterium tuberculosis"],"prefix":"10.1007","volume":"161","author":[{"given":"Qinglai","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Canaday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Mayanja-Kizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Baseke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2060-0674","authenticated-orcid":false,"given":"Zahra","family":"Toossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"2640_CR1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","volume":"59","author":"A Adachi","year":"1986","unstructured":"Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284\u2013291","journal-title":"J Virol"},{"key":"2640_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/0092-8674(94)90360-3","volume":"76","author":"C Aiken","year":"1994","unstructured":"Aiken C, Konner J, Landau NR, Lenburg ME, Trono D (1994) Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853\u2013864","journal-title":"Cell"},{"key":"2640_CR3","first-page":"225","volume":"5","author":"M Badri","year":"2001","unstructured":"Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G (2001) Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis 5:225\u2013232","journal-title":"Int J Tuberc Lung Dis"},{"key":"2640_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1084\/jem.176.4.1099","volume":"176","author":"NK Banda","year":"1992","unstructured":"Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH (1992) Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176:1099\u20131106","journal-title":"J Exp Med"},{"key":"2640_CR5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1084\/jem.177.6.1561","volume":"177","author":"RE Benson","year":"1993","unstructured":"Benson RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR (1993) Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med 177:1561\u20131566","journal-title":"J Exp Med"},{"key":"2640_CR6","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1128\/JVI.70.9.6044-6053.1996","volume":"70","author":"BK Chen","year":"1996","unstructured":"Chen BK, Gandhi RT, Baltimore D (1996) CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J Virol 70:6044\u20136053","journal-title":"J Virol"},{"key":"2640_CR7","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1128\/JVI.76.4.1697-1706.2002","volume":"76","author":"KR Collins","year":"2002","unstructured":"Collins KR, Quinones-Mateu ME, Wu M, Luzze H, Johnson JL, Hirsch C, Toossi Z, Arts EJ (2002) Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J Virol 76:1697\u20131706","journal-title":"J Virol"},{"key":"2640_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EL Corbett","year":"2003","unstructured":"Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009\u20131021","journal-title":"Arch Intern Med"},{"key":"2640_CR9","doi-asserted-by":"publisher","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","volume":"74","author":"CA Derdeyn","year":"2000","unstructured":"Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O\u2019Brien WA, Ratner L, Kappes JC, Shaw GM, Hunter E (2000) Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 74:8358\u20138367","journal-title":"J Virol"},{"key":"2640_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.282.7.677","volume":"282","author":"C Dye","year":"1999","unstructured":"Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677\u2013686","journal-title":"JAMA"},{"key":"2640_CR11","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1128\/JVI.69.6.3949-3954.1995","volume":"69","author":"EO Freed","year":"1995","unstructured":"Freed EO, Englund G, Martin MA (1995) Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 69:3949\u20133954","journal-title":"J Virol"},{"key":"2640_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/350508a0","volume":"350","author":"JV Garcia","year":"1991","unstructured":"Garcia JV, Miller AD (1991) Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350:508\u2013511","journal-title":"Nature"},{"key":"2640_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/aid.1994.10.343","volume":"10","author":"JS Gibbs","year":"1994","unstructured":"Gibbs JS, Regier DA, Desrosiers RC (1994) Construction and in vitro properties of HIV-1 mutants with deletions in \u201cnonessential\u201d genes. AIDS Res Hum Retroviruses 10:343\u2013350","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2640_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1086\/318817","volume":"183","author":"CS Hirsch","year":"2001","unstructured":"Hirsch CS, Toossi Z, Johnson JL, Luzze H, Ntambi L, Peters P, McHugh M, Okwera A, Joloba M, Mugyenyi P, Mugerwa RD, Terebuh P, Ellner JJ (2001) Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J Infect Dis 183:779\u2013788","journal-title":"J Infect Dis"},{"key":"2640_CR15","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/QAD.0b013e3281e209e6","volume":"21","author":"GJ Hughes","year":"2007","unstructured":"Hughes GJ, Willey SJ, Cochrane A, Leen C, Bell JE, Simmonds P (2007) Virus immunocapture provides evidence of CD8 lymphocyte-derived HIV-1 in vivo. AIDS 21:1507\u20131513","journal-title":"AIDS"},{"key":"2640_CR16","first-page":"Unit 26.5","volume":"Chapter 26","author":"AM Janas","year":"2009","unstructured":"Janas AM, Wu L (2009) HIV-1 interactions with cells: from viral binding to cell-cell transmission. Curr Protoc Cell Biol Chapter 26:Unit 26.5","journal-title":"Curr Protoc Cell Biol"},{"key":"2640_CR17","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1128\/JVI.00492-07","volume":"81","author":"P Kaiser","year":"2007","unstructured":"Kaiser P, Joos B, Niederost B, Weber R, Gunthard HF, Fischer M (2007) Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4\/CD8 double-negative T lymphocytes. J Virol 81:9693\u20139706","journal-title":"J Virol"},{"key":"2640_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/aid.1989.5.613","volume":"5","author":"T Kerkau","year":"1989","unstructured":"Kerkau T, Schmitt-Landgraf R, Schimpl A, Wecker E (1989) Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res Hum Retroviruses 5:613\u2013620","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2640_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/eji.200424944","volume":"34","author":"G Lauvau","year":"2004","unstructured":"Lauvau G, Glaichenhaus N (2004) Mini-review: presentation of pathogen-derived antigens in vivo. Eur J Immunol 34:913\u2013920","journal-title":"Eur J Immunol"},{"key":"2640_CR20","doi-asserted-by":"publisher","first-page":"11958","DOI":"10.1073\/pnas.96.21.11958","volume":"96","author":"G Marodon","year":"1999","unstructured":"Marodon G, Warren D, Filomio MC, Posnett DN (1999) Productive infection of double-negative T cells with HIV in vivo. Proc Natl Acad Sci USA 96:11958\u201311963","journal-title":"Proc Natl Acad Sci USA"},{"key":"2640_CR21","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1164\/ajrccm.155.3.9117038","volume":"155","author":"K Nakata","year":"1997","unstructured":"Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M (1997) Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 155:996\u20131003","journal-title":"Am J Respir Crit Care Med"},{"key":"2640_CR22","first-page":"67","volume":"371","author":"SJ Neil","year":"2013","unstructured":"Neil SJ (2013) The antiviral activities of tetherin. Curr Top Microbiol Immunol 371:67\u2013104","journal-title":"Curr Top Microbiol Immunol"},{"key":"2640_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","volume":"451","author":"SJ Neil","year":"2008","unstructured":"Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425\u2013430","journal-title":"Nature"},{"key":"2640_CR24","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","volume":"72","author":"EJ Platt","year":"1998","unstructured":"Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72:2855\u20132864","journal-title":"J Virol"},{"key":"2640_CR25","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.68.8.5156-5163.1994","volume":"68","author":"SS Rhee","year":"1994","unstructured":"Rhee SS, Marsh JW (1994) Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J Virol 68:5156\u20135163","journal-title":"J Virol"},{"key":"2640_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00126334-200103010-00001","volume":"26","author":"K Saha","year":"1999","unstructured":"Saha K, Zhang J (1999) Zerhouni B (2001) Evidence of productively infected CD8+ T cells in patients with AIDS: implications for HIV-1 pathogenesis. J Acquir Immune Defic Syndr 26:199\u2013207","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2640_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1073\/pnas.94.3.873","volume":"94","author":"A Sanfridson","year":"1997","unstructured":"Sanfridson A, Hester S, Doyle C (1997) Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells. Proc Natl Acad Sci USA 94:873\u2013878","journal-title":"Proc Natl Acad Sci USA"},{"key":"2640_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nm0396-338","volume":"2","author":"O Schwartz","year":"1996","unstructured":"Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338\u2013342","journal-title":"Nat Med"},{"key":"2640_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00042560-200109010-00001","volume":"28","author":"Z Toossi","year":"2001","unstructured":"Toossi Z, Johnson JL, Kanost RA, Wu M, Luzze H, Peters P, Okwera A, Joloba M, Mugyenyi P, Mugerwa RD, Aung H, Ellner JJ, Hirsch CS (2001) Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation. J Acquir Immune Defic Syndr 28:1\u20138","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2640_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1164\/ajrccm.151.1.7812542","volume":"151","author":"C Whalen","year":"1995","unstructured":"Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J (1995) Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 151:129\u2013135","journal-title":"Am J Respir Crit Care Med"},{"key":"2640_CR31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/00002030-200006160-00020","volume":"14","author":"CC Whalen","year":"2000","unstructured":"Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Michael NL, Mugerwa RD, Ellner JJ (2000) Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 14:1219\u20131228","journal-title":"AIDS"},{"key":"2640_CR32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/JVI.66.1.226-234.1992","volume":"66","author":"RL Willey","year":"1992","unstructured":"Willey RL, Maldarelli F, Martin MA, Strebel K (1992) Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol 66:226\u2013234","journal-title":"J Virol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-015-2640-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2640-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T08:20:57Z","timestamp":1589444457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-015-2640-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1007\/s00705-015-2640-7","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,23]]},"assertion":[{"value":"12 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}